Skip to main content
Edward Walsh, MD, Infectious Disease, Rochester, NY

EdwardEWalshMD

Infectious Disease Rochester, NY

Professor, Medicine, University of Rochester School of Medicine & Dentistry

Dr. Walsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Walsh's full profile

Already have an account?

  • Office

    1425 Portland Ave
    Rochester, NY 14621
    Phone+1 585-922-4003
    Fax+1 585-922-5168

Education & Training

  • University of Rochester
    University of RochesterFellowship, Infectious Disease, 1977 - 1979
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1974 - 1977
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2026
  • TX State Medical License
    TX State Medical License 1977 - 1981
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Journal Articles

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates  
    Edward E Walsh, Robert W Frenck, Ann R Falsey, Judith Absalon, Kathleen Neuzil, Vanessa Raabe, Philip R Dormitzer, The New England Journal of Medicine

Press Mentions

  • Examine Highlights Significance of RSV Vaccination for High-Risk Populations
    Examine Highlights Significance of RSV Vaccination for High-Risk PopulationsOctober 29th, 2024
  • RSV Vaccines Effective, but More People Need to Get Them
    RSV Vaccines Effective, but More People Need to Get ThemOctober 28th, 2024
  • Novel Antiviral Appears Effective for Severe RSV in Infants, Toddlers
    Novel Antiviral Appears Effective for Severe RSV in Infants, ToddlersSeptember 25th, 2024
  • Join now to see all

Grant Support

  • Pathogenesis Of RSV Disease In The ElderlyNational Institute Of Allergy And Infectious Diseases2004–2008
  • Pathogenesis Of RSV Disease In The ElderlyNational Institute Of Allergy And Infectious Diseases2003
  • Epidemiology And Immunology Of RSV In The ElderlyNational Institute Of Allergy And Infectious Diseases1999–2002
  • Clinical Import Of Respiratory Syncytial Virus StrainsNational Institute Of Allergy And Infectious Diseases1989–1991
  • Antibody In Respiratory Syncytial Virus InfectionNational Institute Of Allergy And Infectious Diseases1985–1987